Back to Atlas
APotentially durableResearch-only / high verification need
CMP-0045
Discontinued/controlled
Drostanolone propionate / Masteron
Ergogenic / AAS
Hardening/lean-mass support with non-aromatizing DHT-derived profile
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Esterified DHT-derived AAS
- Primary mechanism
- AR agonist; commonly cited A:A ~62:25
- Primary market use
- Breast cancer history; performance misuse
Pharmacology
- Molecular weight (Da)
- 360.53
- Oral bioavailability
- N/A (injectable ester)
- Half-life
- ~2-3 d release-dependent
- Route tags
- Route-dependent / verify
- Evidence level
- Historical/clinical
- Clinical status
- Discontinued/controlled
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Classic ratio values are preclinical index values, not human outcome ratios.